| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/2009 | CN101485884A Inactivated vaccine for Escherichia coli disease of yak as well as preparation method and use thereof |
| 07/22/2009 | CN101485883A Method for preventing and treating asthma |
| 07/22/2009 | CN100516221C Nucleotide sequences of mutant swine fever viral strin, polypeptides encoded by these squences and use thereof |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516219C Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen |
| 07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 07/22/2009 | CN100515496C Immunity regulator and its application |
| 07/22/2009 | CN100515495C Lyophilized preparation containing antibodies to the EGF receptor |
| 07/22/2009 | CN100515494C Immunisation against chlamydia trachomatis |
| 07/21/2009 | US7563883 Recombinant P. falciparum merozoite protein-142 vaccine |
| 07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
| 07/21/2009 | US7563880 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/21/2009 | US7563878 Bacterial phytases and method for producing same |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563874 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/21/2009 | US7563870 LAGE-1 tumor associated nucleic acids |
| 07/21/2009 | US7563866 Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563599 Reshaped human antibody to human medulloblastoma cells |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563568 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | US7563449 Methods for reducing cattle reproductive diseases |
| 07/21/2009 | US7563448 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 07/21/2009 | US7563447 Anticancer agents; mixture of fusion protein and yeast vehicle |
| 07/21/2009 | US7563446 Administering a phosphatidylserine/polypeptide conjugate with polypeptide being bovine serum albumin, keyhole limpet hemocyanin, bovine gamma-globulin, diphtheria toxin, or beta 2-glycoprotein |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563444 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/21/2009 | US7563443 Comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD40L without substantially agonizing CD40 activity; Polyethylene Glycol-linked antibody single variable domain polypeptide |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | US7563441 Anti-P-selectin antibodies |
| 07/21/2009 | US7563440 vaccination against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | US7563438 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 07/21/2009 | US7563437 Methods and compositions for impairing multiplication of HIV-1 |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/21/2009 | CA2261690C Antiprotozoal composition |
| 07/16/2009 | WO2009089401A2 Compositions comprising toll-like receptor or coreceptor antagonists and methods for treating or controlling ocular allergy using same |
| 07/16/2009 | WO2009089399A2 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection |
| 07/16/2009 | WO2009089260A2 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 07/16/2009 | WO2009089149A1 B7-h1 (cd274) antagonists induce apoptosis of tumor cells |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | WO2009088849A2 Treatment or prevention of inflammation by targeting cyclin d1 |
| 07/16/2009 | WO2009088837A2 Methods and products to target, capture and characterize stem cells |
| 07/16/2009 | WO2009088805A2 Antibody targeting through a modular recognition domain |
| 07/16/2009 | WO2009088694A1 Methods for detection of cyclosporin a |
| 07/16/2009 | WO2009088401A2 Immunostimulatory combinations of tlr3 ligands with tlr2 and/or tlr9 agonists and methods of use |
| 07/16/2009 | WO2009088255A2 Method for preparing antigen effective for preventing anthrax infection |
| 07/16/2009 | WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF |
| 07/16/2009 | WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088032A1 Antibody directed against pcrv |
| 07/16/2009 | WO2009087978A1 Anti-cldn6 antibody |
| 07/16/2009 | WO2009087467A2 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 07/16/2009 | WO2009087175A2 Allergy vaccine composition for mucosal administration |
| 07/16/2009 | WO2009087173A2 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
| 07/16/2009 | WO2009086920A1 Anti mif antibodies |
| 07/16/2009 | WO2009086640A1 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 07/16/2009 | WO2009069130A3 New adjuvant |
| 07/16/2009 | WO2009062454A3 Universal vaccine for the treatment and prophylaxis of lyme disease for human and veterinary use and method of its manufacture |
| 07/16/2009 | WO2009056535A3 Methods and kits for inducing a ctl response using a prime boost regimen |
| 07/16/2009 | WO2009046015A3 Combination therapies for treating type 1 diabetes |
| 07/16/2009 | WO2009044272A3 Laser-based vaccine adjuvants |
| 07/16/2009 | WO2009033121A3 Molecules and methods for treatment and detection of diabetes |
| 07/16/2009 | WO2009009759A3 Yersinia pestis antigens, vaccine compositions, and related methods |
| 07/16/2009 | WO2008140353A8 AGENT EXHIBITING PROPERTIES TO FORM THE CELLULAR IMMUNITY AGAINST MYCOBACTERIUM TUBERCULOSIS H37 Rv, METHOD FOR THE PRODUCTION THEREOF (VARIANTS), A RECOMBINANT STRAIN AND AN AGENT FOR TUBERCULOSIS DIAGNOSIS |
| 07/16/2009 | WO2008127840A8 Flavivirus ns5a proteins for the treatment of hiv |
| 07/16/2009 | WO2008127450A8 Linear expression cassette vaccines |
| 07/16/2009 | WO2008125366A3 Treatment of autoimmune diseases |
| 07/16/2009 | WO2008116078A8 Stimulation of an immune response by cationic lipids |
| 07/16/2009 | WO2008110695A8 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 07/16/2009 | WO2008099185A8 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/16/2009 | WO2008094942A8 Humanized antibodies against cxcr3 |
| 07/16/2009 | WO2008090360A8 Methods |
| 07/16/2009 | WO2008079464A8 Stable powder formulations of alum-adsorbed vaccines |
| 07/16/2009 | WO2008017870A8 Attenuated polio viruses |
| 07/16/2009 | WO2008000028A8 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 07/16/2009 | WO2007135390A8 Prevention of plaque formation |
| 07/16/2009 | WO2004055164A3 System and method for stabilizing antibodies with histidine |
| 07/16/2009 | WO2002087497A3 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 07/16/2009 | US20090183268 Methods and systems for medical sequencing analysis |
| 07/16/2009 | US20090182129 Capsular Polysaccharide Solubilisation and Combination Vaccines |
| 07/16/2009 | US20090182128 Capsular Polysaccharide Solubilisation and Combination Vaccines |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181891 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/16/2009 | US20090181393 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 07/16/2009 | US20090181090 Protein-Based Carrier System for Overcoming Resistance in Tumour Cells |
| 07/16/2009 | US20090181078 Vaccine composition containing synthetic adjuvant |
| 07/16/2009 | US20090181056 Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof |
| 07/16/2009 | US20090181055 Gallibacterium anatis isolate BIV-07990 deposited with ATCC under accession number ATCC No.PTA-3669; beta( beta )-haemolysis-positive, Gram-negative, oxidase-positive, catalase-positive, urease-negative, nitrate-positive and indole-negative; for treatment of respiratory diseases in poultry |
| 07/16/2009 | US20090181054 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 07/16/2009 | US20090181053 Capsular polysaccharide solubilisation and combination vaccines |
| 07/16/2009 | US20090181052 Vaccine |
| 07/16/2009 | US20090181051 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 07/16/2009 | US20090181050 Manufacturing Method of Combined Vaccine |
| 07/16/2009 | US20090181049 Capsular polysaccharide solubilisation and combination vaccines |
| 07/16/2009 | US20090181048 Cancer drug delivery using modified transferrin |
| 07/16/2009 | US20090181046 Capsid Proteins and Uses Therefore |
| 07/16/2009 | US20090181045 Tat-based vaccine compositions and methods of making and using same |